Correction: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial.

Autor: Zakaraia, Haitham G., Salem, Heba F., Mostafa, Mostafa A. A., Ali, Ahmed M., Rabea, Hoda M.
Předmět:
Zdroj: Beni-Suef University Journal of Basic & Applied Sciences; 3/29/2024, Vol. 13 Issue 1, p1-1, 1p
Abstrakt: This correction notice is regarding an article titled "Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial." The authors inform readers that this article is the first part of their research on the use of DPP-4 and SGLT-2 inhibitors in Egyptian diabetic patients. The second part of their research, which examines the long-term effects of the medications discussed in the article, can be found elsewhere. The publisher, Springer Nature, remains neutral in terms of jurisdictional claims and institutional affiliations. The authors of the article are Haitham G. Zakaraia, Heba F. Salem, Mostafa A. A. Mostafa, Ahmed M. Ali, and Hoda M. Rabea. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz: